BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD. - Submission Of Unaudited Quarterly Financial Results For The Quarter And Nine Months Ended December 2022 Along With Limited Review Report

Download	< Back
10 Feb 2023
In compliance of SEBI LODR with Stock Exchange, please find enclosed the Unaudited Quarterly Financial Results for the quarter and nine months ended December 2022 along with Limited Review Report, approved by the Board of the Company in its Meeting held on 09.02.2023.
View all announcements for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us